These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

465 related items for PubMed ID: 10870526

  • 1. Modulation of ocular hydrodynamics and iris function by bremazocine, a kappa opioid receptor agonist.
    Russell KR, Wang DR, Potter DE.
    Exp Eye Res; 2000 May; 70(5):675-82. PubMed ID: 10870526
    [Abstract] [Full Text] [Related]

  • 2. Dynorphin modulates ocular hydrodynamics and releases atrial natriuretic peptide via activation of kappa-Opioid receptors.
    Russell KR, Potter DE.
    Exp Eye Res; 2002 Sep; 75(3):259-70. PubMed ID: 12384089
    [Abstract] [Full Text] [Related]

  • 3. Aqueous humor dynamics in monkeys in response to the kappa opioid agonist bremazocine.
    Rasmussen CA, Gabelt BT, Kaufman PL.
    Trans Am Ophthalmol Soc; 2007 Sep; 105():225-38; discussion 238-9. PubMed ID: 18427613
    [Abstract] [Full Text] [Related]

  • 4. Bremazocine increases C-type natriuretic peptide levels in aqueous humor and enhances outflow facility.
    Potter DE, Russell KR, Manhiani M.
    J Pharmacol Exp Ther; 2004 May; 309(2):548-53. PubMed ID: 14742737
    [Abstract] [Full Text] [Related]

  • 5. Kappa opioid agonist-induced changes in IOP: correlation with 3H-NE release and cAMP accumulation.
    Moore TT, Potter DE.
    Exp Eye Res; 2001 Aug; 73(2):167-78. PubMed ID: 11446767
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Apraclonidine and brimonidine effects on anterior ocular and cardiovascular physiology in normal and sympathectomized monkeys.
    Gabelt BT, Robinson JC, Hubbard WC, Peterson CM, Debink N, Wadhwa A, Kaufman PL.
    Exp Eye Res; 1994 Dec; 59(6):633-44. PubMed ID: 7698258
    [Abstract] [Full Text] [Related]

  • 8. Morphine-induced reduction of intraocular pressure and pupil diameter: role of nitric oxide.
    Dortch-Carnes J, Russell KR.
    Pharmacology; 2006 Dec; 77(1):17-24. PubMed ID: 16534251
    [Abstract] [Full Text] [Related]

  • 9. Ocular hypotensive action of a dopaminergic (DA2) agonist, 2,10,11-trihydroxy-N-n-propylnoraporphine.
    Ogidigben M, Chu TC, Potter DE.
    J Pharmacol Exp Ther; 1993 Nov; 267(2):822-7. PubMed ID: 7902435
    [Abstract] [Full Text] [Related]

  • 10. Contributions of adenosine receptor activation to the ocular actions of epinephrine.
    Crosson CE, Petrovich M.
    Invest Ophthalmol Vis Sci; 1999 Aug; 40(9):2054-61. PubMed ID: 10440261
    [Abstract] [Full Text] [Related]

  • 11. Ocular actions of moxonidine: a possible role for imidazoline receptors.
    Ogidigben M, Chu TC, Potter DE.
    J Pharmacol Exp Ther; 1994 Jun; 269(3):897-904. PubMed ID: 7912282
    [Abstract] [Full Text] [Related]

  • 12. Possible involvement of nitric oxide in morphine-induced miosis and reduction of intraocular pressure in rabbits.
    Bonfiglio V, Bucolo C, Camillieri G, Drago F.
    Eur J Pharmacol; 2006 Mar 18; 534(1-3):227-32. PubMed ID: 16516192
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Biphasic alterations of cAMP levels and inhibition of norepinephrine release in iris-ciliary body by bremazocine.
    Russell KR, Potter DE.
    J Pharmacol Exp Ther; 2001 Sep 18; 298(3):941-6. PubMed ID: 11504788
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of 15-keto latanoprost on intraocular pressure and aqueous humor dynamics in monkey eyes.
    Wang RF, Gagliuso DJ, Mittag TW, Podos SM.
    Invest Ophthalmol Vis Sci; 2007 Sep 18; 48(9):4143-7. PubMed ID: 17724199
    [Abstract] [Full Text] [Related]

  • 17. Intraocular pressure responses to the adenosine agonist cyclohexyladenosine: evidence for a dual mechanism of action.
    Crosson CE.
    Invest Ophthalmol Vis Sci; 2001 Jul 18; 42(8):1837-40. PubMed ID: 11431451
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Adrenergic mechanism in circadian elevation of intraocular pressure in rabbits.
    Liu JH, Dacus AC, Bartels SP.
    Invest Ophthalmol Vis Sci; 1991 Jul 18; 32(8):2178-83. PubMed ID: 1676991
    [Abstract] [Full Text] [Related]

  • 20. Ocular hypotensive and aqueous outflow-enhancing effects of AL-3037A (sodium ferri ethylenediaminetetraacetate).
    Pang IH, Moll H, McLaughlin MA, Knepper PA, De Santis L, Epstein DL, Clark AF.
    Exp Eye Res; 2001 Dec 18; 73(6):815-25. PubMed ID: 11846512
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.